Effects of prolonged phenothiazine intake on psychotic and other hospitalized children.
D000293:Adolescent; D001835:Body Weight / Q000187:drug effects; D002386:Cataract / Q000139:chemically induced; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy; D002673:Child, Hospitalized; D002675:Child, Preschool; D002746:Chlorpromazine / Q000009:adverse effects; D003318:Corneal Opacity / Q000139:chemically induced; D005069:Evaluation Studies as Topic; D005260:Female; D006778:Hospitals, Psychiatric; D006801:Humans; D007360:Intelligence / Q000187:drug effects; D008297:Male; D009069:Movement Disorders / Q000139:chemically induced; D010554:Personality Disorders / Q000188:drug therapy; D010640:Phenothiazines / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D011618:Psychotic Disorders / Q000188:drug therapy*; D012189:Retrospective Studies; D012561:Schizophrenia, Childhood / Q000188:drug therapy; D013881:Thioridazine / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D010640:Phenothiazines; D014149:Tranquilizing Agents; D013881:Thioridazine; D002746:Chlorpromazine